Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid Maintenance in Elderly AML Post-ASCT
NCT02038153Phase 2Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Dec 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in acute myeloid leukemia (AML), sponsored by Albert Einstein College of Medicine. Started Dec 2013; status: terminated.
02
Drugs
lenalidomide
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02038153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038153.